Top

European Journal of Clinical Microbiology & Infectious Diseases

Published in:

01-08-2014 | Review

Mycobacterium chelonae peritonitis in peritoneal dialysis. Literature review

Authors: M. Kunin, A. Knecht, E. J. Holtzman

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 8/2014

Abstract

Non-tuberculous mycobacteria are a rare but serious cause of peritoneal dialysis-related peritonitis. There are no clear guidelines for treating non-tuberculous mycobacteria peritoneal dialysis-associated infections. It has been recommended that at least two antibiotics be given for a prolonged period and peritoneal catheter should be removed. This paper describes the clinical course and treatment of a patient with M. chelonae peritoneal dialysis-related peritonitis and reviews the previously published cases.

Griffith DE, Aksamit T, Brown-Elliott BA et al (2007) An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175:367–416PubMedCrossRef

Jarzembowski JA, Young MB (2008) Nontuberculous mycobacterial infections. Arch Pathol Lab Med 132:1333–1341PubMed

Li PK-T, Szeto CC, Piraino B, Bernardini J, Figueiredo AE, Gupta A, Johnson DW, Kuijper EJ, Lye W-C, Salzer W, Schaefer F, Dirk G, Struijk DG (2010) Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int 30:393–423PubMedCrossRef

Hevia C, Bajo MA, Sanchez-Tomero JA, del Peso G, Fernandez-Perpen A, Millan I, Aguilera A, Selgas R (2000) Peritoneal catheter exit-site infections caused by rapidly-growing atypical mycobacteria. Nephrol Dial Transplant 15:1458–1460PubMedCrossRef

Lee KF, Chen HH, Wu CJ (2008) Mycobacterium chelonae peritonitis in a patient on peritoneal dialysis. Ren Fail 30:335–338PubMedCrossRef

Selgas R, Munoz J, Aquella A, Huarte E, Fonseca E, Escuin F, Contreras F (1987) Mycobacterium chelonei peritonitis due to hematogenous dissemination in a continuous ambulatory peritoneal dialysis patient. Am J Kidney Dis 10:144–146PubMedCrossRef

Poisson M, Beroniade V, Falardeau P, Vega C, Morisset R (1983) Mycobacterium chelonei peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Bull 3:86–88

Merlin TL, Tzamaloukas AH (1989) Mycobacterium chelonae peritonitis associated with continuous ambulatory peritoneal dialysis. Am J Clin Pathol 91:717–720PubMed

Rho M, Bia F, Brewster UC (2007) Nontuberculous mycobacterial peritonitis in peritoneal dialysis patients. Semin Dial 20:271–276PubMedCrossRef

10.

Renaud CJ, Subramanian S, Tambyah PA, Lee E (2011) The clinical course of rapidly growing nontuberculous mycobacterial peritoneal dialysis infections in Asians: a case series and literature review. Nephrology (Carlton) 16:174–179CrossRef

11.

Jiang SH, Roberts DM, Clayton PA, Jardine M (2013) Non-tuberculous mycobacterial PD peritonitis in Australia. Int Urol Nephrol 45:1423–1428PubMedCrossRef

12.

Gehr TW, Walters BA (1994) Catheter-related Mycobacterium chelonei infection in a CAPD patient. Perit Dial Int 14:278–279PubMed

13.

Siu YP, Leung KT, Tong MK, Lee MK (2005) Mycobacterium chelonae exit site infection in a patient on peritoneal dialysis. Clin Nephrol 63:321–324PubMedCrossRef

14.

Kleinpeter MA, Krane NK (2001) Treatment of mycobacterial exit-site infections in patients on continuous ambulatory peritoneal dialysis. Adv Perit Dial 17:172–175PubMed

15.

Tse KC, Lui SL, Cheng VCC, Yip TPS, Lo WK (2007) A cluster of rapidly growing mycobacterial peritoneal dialysis catheter exit-site infections. Am J Kidney Dis 50:1–5CrossRef

16.

Wallace RJ, Swenson JM, Silcox VA, Good RC, Tschen JA, Stone MS (1983) Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis 5:657–679PubMedCrossRef

17.

Wallace RJ Jr, Tanner D, Brennan PJ, Brown BA (1993) Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. Ann Intern Med 119:482–486PubMedCrossRef

18.

Song Y, Wu J, Yan H, Chen J (2012) Peritoneal dialysis-associated nontuberculous mycobacterium peritonitis: a systematic review of reported cases. Nephrol Dial Transplant 27:1639–1644PubMedCrossRef

19.

Pulliam JP, Vernon DD, Alexander SR, Hartstein AI, Golper TA (1983) Nontuberculous mycobacterial peritonitis associated with continuous ambulatory peritoneal dialysis. Am J Kidney Dis 2:610–614PubMedCrossRef

20.

Falkinham JO 3rd, Norton CD, LeChevallier MW (2001) Factors influencing numbers of Mycobacterium avium, Mycobacterium intracellulare, and other Mycobacteria in drinking water distribution systems. Appl Environ Microbiol 67:1225–1231PubMedCentralPubMedCrossRef

21.

Goslee S, Wolinsky E (1976) Water as a source of potentially pathogenic mycobacteria. Am Rev Respir Dis 113(3):287–292PubMed

22.

Bolan G, Reingold AL, Carson LA et al (1985) Infections with Mycobacterium chelonei in patients receiving dialysis and using processed hemodialyzers. J Infect Dis 152:1013–1019PubMedCrossRef

23.

Kline S, Cameron S, Streifel A, Yakrus MA, Kairis F, Peacock K, Besser J, Cooksey RC (2004) An outbreak of bacteremias associated with Mycobacerium mucogenicum in a hospital water supply. Infect Control Hosp Epidemiol 25:1042–1049PubMedCrossRef

24.

Wallace RJ Jr (1987) Nontuberculous mycobacteria and water: A love affair with increasing clinical importance. Infect Dis Clin North Am 1:677–686PubMed

25.

Band JD, Ward JI, Fraser DW, Peterson NJ, Silcox VA, Good RC, Ostroy PR, Kennedy J (1987) Peritonitis due to a mycobacterium chelonei-like organism associated with intermittent chronic peritoneal dialysis. Infect Dis Clin North Am 1:677–686

26.

Rubin J, Lin LM, Lewis R, Cruse J, Bower JD (1983) Host defense mechanisms in continuous ambulatory peritoneal dialysis. Clin Nephrol 20:140–144PubMed

27.

Kazancioglu R (2009) Peritoneal defense mechanisms—the effects of new peritoneal dialysis solutions. Perit Dial Int 29(Suppl 2):S198–S201PubMed

Title: Mycobacterium chelonae peritonitis in peritoneal dialysis. Literature review
Authors: M. Kunin
A. Knecht
E. J. Holtzman
Publication date: 01-08-2014
Publisher: Springer Berlin Heidelberg
Published in: European Journal of Clinical Microbiology & Infectious Diseases / Issue 8/2014
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-014-2079-x

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 8/2014

MicroRNA expressions associated with eosinophilic meningitis caused by Angiostrongylus cantonensis infection in a mouse model

Scalp eschar and neck lymphadenopathy after tick bite: an emerging syndrome with multiple causes

Probiotics in respiratory virus infections

Streptococcus dysgalactiae subsp. equisimilis bacteremia: an emerging infection

MALDI-TOF mass spectrometry as a tool for the discrimination of high-risk Escherichia coli clones from phylogenetic groups B2 (ST131) and D (ST69, ST405, ST393)

Seasonal trend and clinical presentation of Bacillus cereus bloodstream infection: association with summer and indwelling catheter

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials